Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Barba

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Kidney International|July 20, 2021
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysisMaxime Espi, Xavier Charmetant, Thomas Barba, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2022
Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatmentAntonin Bouchet, Brieuc Muller, Jerome Olagne, et al.
Journal of Medical Virology|July 15, 2024
Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long-term complications of inadequate immunosuppressionLuc Chauvelot, Thomas Barba, Carole Saison, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2020
Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated RejectionAlice Koenig, Sarah Mezaache, Jasper Callemeyn, et al.
Kidney International|December 2, 2021
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysisMaxime Espi, Xavier Charmetant, Thomas Barba, et al.
Frontiers in Immunology|March 14, 2022
Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological FindingsElisabet Van Loon, Baptiste Lamarthée, Thomas Barba, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2025
γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental ModelsXavier Charmetant, Guillaume Rigault, Chien-Chia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2026
Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejectionSarah Hamada, Jack Beadle, Alice Koenig, et al.
The Journal of Clinical Investigation|May 28, 2025
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejectionThomas Barba, Martin Oberbarnscheidt, Gregory Franck, et al.
Nature Communications|November 27, 2019
Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplantsAlice Koenig, Chien-Chia Chen, Antoine Marçais, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Kidney International|July 20, 2021
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysisMaxime Espi, Xavier Charmetant, Thomas Barba, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2022
Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatmentAntonin Bouchet, Brieuc Muller, Jerome Olagne, et al.
Journal of Medical Virology|July 15, 2024
Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long-term complications of inadequate immunosuppressionLuc Chauvelot, Thomas Barba, Carole Saison, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2020
Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated RejectionAlice Koenig, Sarah Mezaache, Jasper Callemeyn, et al.
Kidney International|December 2, 2021
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysisMaxime Espi, Xavier Charmetant, Thomas Barba, et al.
Frontiers in Immunology|March 14, 2022
Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological FindingsElisabet Van Loon, Baptiste Lamarthée, Thomas Barba, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2025
γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental ModelsXavier Charmetant, Guillaume Rigault, Chien-Chia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2026
Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejectionSarah Hamada, Jack Beadle, Alice Koenig, et al.
The Journal of Clinical Investigation|May 28, 2025
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejectionThomas Barba, Martin Oberbarnscheidt, Gregory Franck, et al.
Nature Communications|November 27, 2019
Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplantsAlice Koenig, Chien-Chia Chen, Antoine Marçais, et al.
Pageof 4